MelaB3 Serum with glycolic acid peel for skin darkening
Part of Skin clinical trials.
This study tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for different types of dark skin patches (like melasma, dark marks after acne, or sun spots). Participants will have several treatments and be monitored for about a few months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 70 years old.
- You must have a type of dark skin patch (like melasma, post-acne dark spots, or sun spots) that is mild to moderate.
- You must be willing to protect your skin from the sun during the study.
- You must agree to avoid other skin-lightening or irritating products on your face.
- You must not be pregnant or planning pregnancy, and not have certain skin conditions or recent facial procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a serum with ingredients like niacinamide to improve dark spots from acne and melasma, used alongside a laser treatment. It aims to see if the serum makes the laser more effective at lightening skin patches.
This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.
This study tests a cosmetic cream to reduce dark spots on the face, including melasma and sun spots. It aims to see if the product improves the appearance of hyperpigmentation.
This study tests whether a medicine called tranexamic acid, taken as a pill or used on the skin, can help fade melasma in women with darker skin types. It aims to find a safe way to improve skin color and is relevant to those looking for new melasma treatment options. The trial compares the treatment to another study treatment without medicine. Participation is open to women aged 30 to 60 with darker skin tones who are not pregnant and are not using certain other skin or hormone treatments.
Hear when a new Hyperpigmentation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.